Antiviral immune responses in H5N1-infected human lung tissue and possible mechanisms underlying the hyperproduction of interferon-inducible protein IP-10.

[1]  Y. Guan,et al.  Influenza H5N1 virus infection of polarized human alveolar epithelial cells and lung microvascular endothelial cells , 2009, Respiratory research.

[2]  Carole R. Baskin,et al.  Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus , 2009, Proceedings of the National Academy of Sciences.

[3]  T. Kuijpers,et al.  Infiltrated Neutrophils Acquire Novel Chemokine Receptor Expression and Chemokine Responsiveness in Chronic Inflammatory Lung Diseases , 2008, The Journal of Immunology.

[4]  C. Korteweg,et al.  Distinctly different expression of cytokines and chemokines in the lungs of two H5N1 avian influenza patients , 2008, The Journal of pathology.

[5]  Ali Danesh,et al.  Gene Expression Analysis of Host Innate Immune Responses during Lethal H5N1 Infection in Ferrets , 2008, Journal of Virology.

[6]  Kazuo Suzuki,et al.  H5N1-infected cells in lung with diffuse alveolar damage in exudative phase from a fatal case in Vietnam. , 2008, Japanese journal of infectious diseases.

[7]  M. Fukuda,et al.  High Susceptibility of Human Dendritic Cells to Avian Influenza H5N1 Virus Infection and Protection by IFN-α and TLR Ligands1 , 2007, The Journal of Immunology.

[8]  Howard Wang,et al.  Controls for Lung Dendritic Cell Maturation and Migration during Respiratory Viral Infection1 , 2007, The Journal of Immunology.

[9]  G. Kochs,et al.  The Mx1 Gene Protects Mice against the Pandemic 1918 and Highly Lethal Human H5N1 Influenza Viruses , 2007, Journal of Virology.

[10]  Mustapha Si-Tahar,et al.  Cutting Edge: Influenza A Virus Activates TLR3-Dependent Inflammatory and RIG-I-Dependent Antiviral Responses in Human Lung Epithelial Cells1 , 2007, The Journal of Immunology.

[11]  Yi Guan,et al.  Three Indonesian clusters of H5N1 virus infection in 2005. , 2006, The New England journal of medicine.

[12]  Yi Guan,et al.  Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia , 2006, Nature Medicine.

[13]  P. Österlund,et al.  TNF-α and IFN-α enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells , 2006 .

[14]  K. Melén,et al.  TNF-alpha and IFN-alpha enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells. , 2006, Virology.

[15]  Y. Guan,et al.  Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells , 2005, Respiratory research.

[16]  J. Nicholls,et al.  Influenza A H5N1 Replication Sites in Humans , 2005, Emerging infectious diseases.

[17]  A. Morgan,et al.  Differential expression of CCR3 and CXCR3 by human lung and bone marrow‐derived mast cells: implications for tissue mast cell migration , 2005, Journal of leukocyte biology.

[18]  D. Corry,et al.  An Immune Basis for Lung Parenchymal Destruction in Chronic Obstructive Pulmonary Disease and Emphysema , 2004, PLoS medicine.

[19]  Akiko Iwasaki,et al.  Recognition of single-stranded RNA viruses by Toll-like receptor 7. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Peiris,et al.  Re-emergence of fatal human influenza A subtype H5N1 disease , 2004, The Lancet.

[21]  Y. Guan,et al.  Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? , 2002, The Lancet.

[22]  B. Sykes,et al.  The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions. , 2002, Biochemistry.

[23]  L. Adorini,et al.  Cutting Edge: Selective Usage of Chemokine Receptors by Plasmacytoid Dendritic Cells1 , 2001, The Journal of Immunology.

[24]  R. Sung,et al.  Pathology of fatal human infection associated with avian influenza A H5N1 virus , 2001, Journal of medical virology.

[25]  K. Nagata,et al.  [The Mx protein that confers the resistance to influenza virus]. , 1997, Nihon rinsho. Japanese journal of clinical medicine.